Global Cell Therapy Market to Reach US$ 32.1 Billion by 2028, Propelled by Extensive R&D Activities on Stem Cell Therapy

September 30, 2022

According to the latest report by IMARC Group, titled “Cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global cell therapy market size reached US$ 11.5 Billion in 2022. Cell therapy (CT) replaces or repairs damaged tissues and cells by using human cells as transplants. This technology is used to develop and apply new techniques to restore function and heal tissues and organs inflicted by aging, disease, and damage. The therapy also improves the immune system of the body to combat cancer cells. Cell therapy can also be used to treat numerous autoimmune and infectious diseases, urinary problems, joint damage, spinal cord injuries, weakened immune systems, and neurological disorders.

Global Cell Therapy Market Trends:

The global market is majorly driven by the rising incidences of numerous chronic diseases, including cancer and cardiovascular disorders. In line with this, the increasing promotions of clinical trials by various governing agencies of several countries are contributing to the growth of the market. Moreover, the extensive research and development (R&D) activities conducted by key players regarding stem cell therapy are providing an impetus to the market. In addition to this, the introduction of advanced cell-based therapies, such as direct cell reprogramming for neuronal tissue replacement, skin rejuvenation and tendon regeneration therapies, is creating a positive market outlook. Furthermore, continual technological advancements in the healthcare infrastructure are acting as another significant growth-inducing factor. Some of the other factors contributing to the market growth include the escalating demand for regenerative drugs and a considerable increase in medical expenditure. On account of the aforementioned factors, the market is anticipated to reach a value of US$ 32.1 Billion by 2028, exhibiting a CAGR of 17.5% during 2023-2028.

Market Summary:

  • Based on the cell type, the market has been segmented into stem cell (bone marrow, blood, umbilical cord-derived, adipose-derived stem cell and others) and non-stem cell.
  • On the basis of the therapy type, the market has been divided into autologous and allogeneic.
  • Based on the therapeutic area, the market has been categorized into malignancies, musculoskeletal disorders, autoimmune disorders, dermatology, and others.
  • On the basis of the end user, the market has been classified into hospitals and clinics and academic and research institutes.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include AlloSource, Anterogen Co. Ltd., Cells for Cells, Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals, Kolon TissueGene Inc., MEDIPOST, Mesoblast Limited, NuVasive, Stemedica Cell Technologies Inc., Stempeutics Research Pvt. Ltd, and Vericel Corporation.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cell Therapy Market to Reach US$ 32.1 Billion by 2028, Propelled by Extensive R&D Activities on Stem Cell Therapy
Purchase options Year End sale

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More